Literature DB >> 30856103

The clinical role of contrast enhanced ultrasound in differential diagnosis of BI-RADS 4 breast disease.

Juan Quan1, Yurong Hong1, Xu Zhang1, Mei Mei1, Xiangdong You1, Pintong Huang1.   

Abstract

OBJECTIVE: To clarify the clinical role of contrast enhanced ultrasound (CEUS) in predicting BI-RADS 4 breast disease.
METHODS: A total of 92 sites of BI-RADS 4 breast diseases were reassessed by routine ultrasound and CEUS. The main indicators of routine ultrasound, CEUS and the combination of the two modalities were picked up by binary logistic regression analysis, scoring 0 for benign and 1 for malignant characteristics with pathology as referential standard to generate corresponding score systems of them. Finally, the receiver operating characteristic curves (ROC) were applied to compare the diagnostic efficacy of the three score systems.
RESULTS: As pathological results showing, there were 43 malignant and 49 benign sites in total. Binary logistic regression analysis indicated that the margin, micro-calcification, and hyperechoic halo were main indicators for routine ultrasound score system. The scope expansion and pathological vessels in CEUS were main indicators for CEUS score system. The microcalcification, hyperechoic halo, the scope expansion and pathological vessels in CEUS were main indicators for the combination score system of the two modalities. The sensitivity, specificity and the area under ROC curve (AUC) of routine US, CEUS and the combination of the two modalities score systems were 74.4%, 91.8%, 0.885 and 88.4%, 87.8%, 0.901 and 86.0%, 95.9%, 0.937, respectively.
CONCLUSION: In summary, CEUS is helpful for us to identify malignant disease and plays a supplementary role in predicting BI-RADS 4 breast disease in some extent. The scope expansion and pathological vessels in CEUS may be the most useful indicators.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30856103     DOI: 10.3233/CH-180495

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  3 in total

1.  Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesions.

Authors:  Eva Janu; Lucie Krikavova; Jirina Little; Karel Dvorak; Dagmar Brancikova; Eva Jandakova; Tomas Pavlik; Petra Kovalcikova; Tomas Kazda; Vlastimil Valek
Journal:  BMC Med Imaging       Date:  2020-06-17       Impact factor: 1.930

2.  Contrast-enhanced ultrasound of granular cell tumor in breast: A case report with review of the literature.

Authors:  Huanyu Wang; Duo Feng; Tianhui Zou; Yao Liu; Xiaoqin Wu; Jiawei Zou; Rong Huang
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

3.  The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.

Authors:  Fan Zhang; Lifang Jin; Gang Li; Chao Jia; Qiusheng Shi; Lianfang Du; Rong Wu
Journal:  Br J Radiol       Date:  2021-02-09       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.